By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Avedro, Inc. 

230 Third Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-768-3400 Fax: 781-768-3401


Medical Device

Company News
Avedro Release: First FDA Approved Cross-Linking Procedures Are Performed On Patients In The U.S. With Progressive Keratoconus 9/28/2016 11:00:40 AM
Avedro Release: Two Studies Demonstrate Promising Results Of PiXL Procedure (Photorefractive Intrastromal Corneal Collagen Cross-Linking) For Non-Invasive Treatment Of Low Myopia 9/12/2016 11:20:44 AM
Avedro Appoints Dr. Reza Zadno as CEO 9/8/2016 11:18:31 AM
Avedro Receives Additional Indication For Photrexa Viscous, Photrexa And The KXL System For The Treatment Of Corneal Ectasia Following Refractive Surgery 7/19/2016 11:40:17 AM
Avedro Wins FDA Approval for Photrexa Viscous, Photrexa and the KXL System for Corneal Cross-Linking 4/19/2016 6:14:12 AM
Avedro CEO Resigns; Pharma Device Maker Snags CE Mark Clearance for its Mosaic Advanced Cross-Linking System 12/28/2015 8:53:29 AM
Massachusetts' Avedro Locks in $32 Million 11/16/2015 6:13:04 AM
China Food And Drug Administration (CFDA) Grants Approval For Avedro, Inc.'s KXL System 11/3/2015 12:04:43 PM
Avedro, Inc. Resubmits New Drug Application To FDA For Corneal Cross-Linking 10/19/2015 10:12:37 AM
Avedro, Inc. Expands Patent Portfolio with Licenses From California Institute of Technology And IROC Innocross 4/14/2015 11:15:44 AM